

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | tachykinin receptor signaling pathway (GO:0007217) | 8.59592847 |
| 2 | positive regulation of uterine smooth muscle contraction (GO:0070474) | 6.15695839 |
| 3 | positive regulation of protein homooligomerization (GO:0032464) | 4.95007695 |
| 4 | cellular response to interferon-alpha (GO:0035457) | 4.83225655 |
| 5 | negative regulation of homotypic cell-cell adhesion (GO:0034111) | 4.65082351 |
| 6 | positive regulation of natural killer cell differentiation (GO:0032825) | 4.49913865 |
| 7 | regulation of uterine smooth muscle contraction (GO:0070472) | 4.32395944 |
| 8 | dopamine biosynthetic process (GO:0042416) | 4.26183456 |
| 9 | positive regulation of defense response to virus by host (GO:0002230) | 4.19249390 |
| 10 | regulation of chronic inflammatory response (GO:0002676) | 4.06376326 |
| 11 | arginine catabolic process (GO:0006527) | 4.02146919 |
| 12 | serotonin metabolic process (GO:0042428) | 4.00869788 |
| 13 | primary amino compound metabolic process (GO:1901160) | 3.98778051 |
| 14 | fucosylation (GO:0036065) | 3.97784457 |
| 15 | detection of light stimulus involved in visual perception (GO:0050908) | 3.81563244 |
| 16 | detection of light stimulus involved in sensory perception (GO:0050962) | 3.81563244 |
| 17 | response to insecticide (GO:0017085) | 3.74982869 |
| 18 | RNA destabilization (GO:0050779) | 3.72303078 |
| 19 | negative regulation of axon guidance (GO:1902668) | 3.59992176 |
| 20 | cochlea development (GO:0090102) | 3.59410146 |
| 21 | positive regulation of monocyte chemotaxis (GO:0090026) | 3.43614573 |
| 22 | lymphocyte apoptotic process (GO:0070227) | 3.41855110 |
| 23 | DNA deamination (GO:0045006) | 3.36291928 |
| 24 | cytidine metabolic process (GO:0046087) | 3.31978308 |
| 25 | cytidine catabolic process (GO:0006216) | 3.31978308 |
| 26 | cytidine deamination (GO:0009972) | 3.31978308 |
| 27 | axoneme assembly (GO:0035082) | 3.31742366 |
| 28 | positive regulation of T-helper 1 type immune response (GO:0002827) | 3.28072291 |
| 29 | alkaloid metabolic process (GO:0009820) | 3.25995168 |
| 30 | lung vasculature development (GO:0060426) | 3.25963822 |
| 31 | negative regulation of axon extension involved in axon guidance (GO:0048843) | 3.23900148 |
| 32 | rRNA catabolic process (GO:0016075) | 3.23263087 |
| 33 | positive regulation of natural killer cell mediated immunity (GO:0002717) | 3.12778138 |
| 34 | proteasome assembly (GO:0043248) | 3.12758922 |
| 35 | prostate epithelial cord arborization involved in prostate glandular acinus morphogenesis (GO:006052 | 3.09884984 |
| 36 | regulation of natural killer cell differentiation (GO:0032823) | 3.08734991 |
| 37 | N-acetylglucosamine metabolic process (GO:0006044) | 3.08529622 |
| 38 | sulfation (GO:0051923) | 3.08267423 |
| 39 | hemidesmosome assembly (GO:0031581) | 3.06368393 |
| 40 | regulation of isotype switching to IgG isotypes (GO:0048302) | 3.05300624 |
| 41 | cellular biogenic amine biosynthetic process (GO:0042401) | 3.04452412 |
| 42 | RNA phosphodiester bond hydrolysis, exonucleolytic (GO:0090503) | 3.04286585 |
| 43 | positive regulation of natural killer cell mediated cytotoxicity (GO:0045954) | 3.03873149 |
| 44 | tolerance induction (GO:0002507) | 2.99175464 |
| 45 | response to histamine (GO:0034776) | 2.97722463 |
| 46 | positive regulation of digestive system process (GO:0060456) | 2.90712114 |
| 47 | endoderm formation (GO:0001706) | 2.89812149 |
| 48 | opioid receptor signaling pathway (GO:0038003) | 2.84826225 |
| 49 | catechol-containing compound biosynthetic process (GO:0009713) | 2.83778266 |
| 50 | catecholamine biosynthetic process (GO:0042423) | 2.83778266 |
| 51 | sodium-independent organic anion transport (GO:0043252) | 2.82440019 |
| 52 | regulation of natural killer cell activation (GO:0032814) | 2.80847366 |
| 53 | response to interferon-alpha (GO:0035455) | 2.80237907 |
| 54 | leukocyte apoptotic process (GO:0071887) | 2.79620530 |
| 55 | toxin metabolic process (GO:0009404) | 2.79192575 |
| 56 | amine biosynthetic process (GO:0009309) | 2.79018695 |
| 57 | positive regulation of natural killer cell activation (GO:0032816) | 2.78610089 |
| 58 | mitochondrial calcium ion transport (GO:0006851) | 2.78022655 |
| 59 | purine-containing compound salvage (GO:0043101) | 2.76627644 |
| 60 | positive regulation of protein oligomerization (GO:0032461) | 2.75316998 |
| 61 | regulation of axon guidance (GO:1902667) | 2.74681843 |
| 62 | regulation of monocyte chemotaxis (GO:0090025) | 2.73412256 |
| 63 | macroautophagy (GO:0016236) | 2.73257424 |
| 64 | positive regulation of inflammatory response to antigenic stimulus (GO:0002863) | 2.72600306 |
| 65 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 2.68350436 |
| 66 | retinal cone cell development (GO:0046549) | 2.67983911 |
| 67 | type B pancreatic cell proliferation (GO:0044342) | 2.66966705 |
| 68 | thalamus development (GO:0021794) | 2.66139267 |
| 69 | regulation of tyrosine phosphorylation of Stat5 protein (GO:0042522) | 2.64975925 |
| 70 | regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis (GO:0003339 | 2.64336783 |
| 71 | establishment of skin barrier (GO:0061436) | 2.63069940 |
| 72 | regulation of catecholamine metabolic process (GO:0042069) | 2.62248305 |
| 73 | regulation of dopamine metabolic process (GO:0042053) | 2.62248305 |
| 74 | regulation of homotypic cell-cell adhesion (GO:0034110) | 2.57302213 |
| 75 | positive regulation of smooth muscle contraction (GO:0045987) | 2.56961484 |
| 76 | multicellular organism reproduction (GO:0032504) | 2.55911015 |
| 77 | regulation of gene silencing by RNA (GO:0060966) | 2.55255684 |
| 78 | regulation of posttranscriptional gene silencing (GO:0060147) | 2.55255684 |
| 79 | regulation of gene silencing by miRNA (GO:0060964) | 2.55255684 |
| 80 | interferon-gamma production (GO:0032609) | 2.51621438 |
| 81 | endodermal cell differentiation (GO:0035987) | 2.51356622 |
| 82 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 2.51074695 |
| 83 | ovulation cycle (GO:0042698) | 2.51019221 |
| 84 | desmosome organization (GO:0002934) | 2.50550573 |
| 85 | metanephric mesenchyme development (GO:0072075) | 2.49566943 |
| 86 | positive regulation of tyrosine phosphorylation of Stat5 protein (GO:0042523) | 2.49442797 |
| 87 | phosphatidylethanolamine biosynthetic process (GO:0006646) | 2.48703892 |
| 88 | arginine metabolic process (GO:0006525) | 2.46504083 |
| 89 | positive regulation of cAMP-mediated signaling (GO:0043950) | 2.46401958 |
| 90 | fibroblast migration (GO:0010761) | 2.45706558 |
| 91 | piRNA metabolic process (GO:0034587) | 2.44501653 |
| 92 | kidney mesenchyme development (GO:0072074) | 2.43786821 |
| 93 | negative regulation of astrocyte differentiation (GO:0048712) | 2.43554209 |
| 94 | indolalkylamine metabolic process (GO:0006586) | 2.43276336 |
| 95 | cranial nerve structural organization (GO:0021604) | 2.43184700 |
| 96 | axon extension involved in axon guidance (GO:0048846) | 2.42318141 |
| 97 | neuron projection extension involved in neuron projection guidance (GO:1902284) | 2.42318141 |
| 98 | response to cold (GO:0009409) | 2.42043322 |
| 99 | regulation of T-helper 1 type immune response (GO:0002825) | 2.41702237 |
| 100 | regulation of axon extension involved in axon guidance (GO:0048841) | 2.41651916 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 4.73674553 |
| 2 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 4.47102867 |
| 3 | EZH2_22144423_ChIP-Seq_EOC_Human | 3.97250669 |
| 4 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.25077458 |
| 5 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 2.79565580 |
| 6 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 2.53751894 |
| 7 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 2.47992177 |
| 8 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.34113041 |
| 9 | ZNF274_21170338_ChIP-Seq_K562_Hela | 2.30133206 |
| 10 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 2.27397458 |
| 11 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 2.19022321 |
| 12 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.15748236 |
| 13 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 2.11220273 |
| 14 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 2.06244565 |
| 15 | TAF15_26573619_Chip-Seq_HEK293_Human | 2.00076121 |
| 16 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.98181787 |
| 17 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.91388496 |
| 18 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.91280821 |
| 19 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.85072579 |
| 20 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.81364596 |
| 21 | EWS_26573619_Chip-Seq_HEK293_Human | 1.80708866 |
| 22 | TP63_19390658_ChIP-ChIP_HaCaT_Human | 1.77829165 |
| 23 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.75385526 |
| 24 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.70600809 |
| 25 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.64858991 |
| 26 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.64277386 |
| 27 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.61155163 |
| 28 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.59884045 |
| 29 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.59877400 |
| 30 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.58358300 |
| 31 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.56070692 |
| 32 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.54090716 |
| 33 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.53649522 |
| 34 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.51297561 |
| 35 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.48428295 |
| 36 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.47500525 |
| 37 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 1.45643485 |
| 38 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.45070071 |
| 39 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.44607950 |
| 40 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 1.42602895 |
| 41 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 1.42602895 |
| 42 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.42433259 |
| 43 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.42340120 |
| 44 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.42340120 |
| 45 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.42339833 |
| 46 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.39260035 |
| 47 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.39260035 |
| 48 | RXR_22108803_ChIP-Seq_LS180_Human | 1.37315218 |
| 49 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.35149856 |
| 50 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 1.34984149 |
| 51 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.34437200 |
| 52 | TP53_16413492_ChIP-PET_HCT116_Human | 1.34424097 |
| 53 | P300_19829295_ChIP-Seq_ESCs_Human | 1.29942774 |
| 54 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 1.28518772 |
| 55 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.28246438 |
| 56 | STAT3_23295773_ChIP-Seq_U87_Human | 1.27977249 |
| 57 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 1.26833285 |
| 58 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 1.26212778 |
| 59 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.25372837 |
| 60 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 1.23844907 |
| 61 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.23462691 |
| 62 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.22402947 |
| 63 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.22313807 |
| 64 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.22270301 |
| 65 | OCT4_18555785_Chip-Seq_ESCs_Mouse | 1.21566986 |
| 66 | CJUN_26792858_Chip-Seq_BT549_Human | 1.18088458 |
| 67 | GATA3_21878914_ChIP-Seq_MCF-7_Human | 1.17904507 |
| 68 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.17693822 |
| 69 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.16590008 |
| 70 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.16465771 |
| 71 | ZFX_18555785_Chip-Seq_ESCs_Mouse | 1.15797191 |
| 72 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.15767599 |
| 73 | P53_22387025_ChIP-Seq_ESCs_Mouse | 1.15355428 |
| 74 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 1.15191851 |
| 75 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.14445181 |
| 76 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.12982408 |
| 77 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.12891982 |
| 78 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.12156214 |
| 79 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.11228575 |
| 80 | TCF4_23295773_ChIP-Seq_U87_Human | 1.10362379 |
| 81 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.09241656 |
| 82 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.03337755 |
| 83 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 1.00709131 |
| 84 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.00582391 |
| 85 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.00235173 |
| 86 | ELK4_26923725_Chip-Seq_MESODERM_Mouse | 0.99878562 |
| 87 | NFYA_21822215_ChIP-Seq_K562_Human | 0.99218501 |
| 88 | ER_23166858_ChIP-Seq_MCF-7_Human | 0.98803679 |
| 89 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 0.98451661 |
| 90 | HTT_18923047_ChIP-ChIP_STHdh_Human | 0.98197087 |
| 91 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 0.97784617 |
| 92 | NANOG_19829295_ChIP-Seq_ESCs_Human | 0.97740511 |
| 93 | SOX2_19829295_ChIP-Seq_ESCs_Human | 0.97740511 |
| 94 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.97698789 |
| 95 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.97554477 |
| 96 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 0.97318167 |
| 97 | NMYC_18555785_Chip-Seq_ESCs_Mouse | 0.96367263 |
| 98 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 0.96223421 |
| 99 | KLF4_25985364_ChIP-Seq_ATHEROSCLEROSIS_LESION_Mouse | 0.96090462 |
| 100 | PHF8_20622853_ChIP-Seq_HELA_Human | 0.96034557 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0000569_abnormal_digit_pigmentation | 6.11040263 |
| 2 | MP0005075_abnormal_melanosome_morpholog | 3.60258072 |
| 3 | MP0008004_abnormal_stomach_pH | 3.38777511 |
| 4 | MP0003950_abnormal_plasma_membrane | 2.81283703 |
| 5 | MP0001348_abnormal_lacrimal_gland | 2.80162048 |
| 6 | MP0002163_abnormal_gland_morphology | 2.74492150 |
| 7 | MP0001346_abnormal_lacrimal_gland | 2.61462336 |
| 8 | MP0004742_abnormal_vestibular_system | 2.49062829 |
| 9 | MP0006082_CNS_inflammation | 2.40009186 |
| 10 | MP0008875_abnormal_xenobiotic_pharmacok | 2.39344979 |
| 11 | MP0000566_synostosis | 2.38339774 |
| 12 | MP0004381_abnormal_hair_follicle | 2.11585118 |
| 13 | MP0000579_abnormal_nail_morphology | 2.07026426 |
| 14 | MP0001958_emphysema | 1.97639851 |
| 15 | MP0008438_abnormal_cutaneous_collagen | 1.92351715 |
| 16 | MP0000685_abnormal_immune_system | 1.88388529 |
| 17 | MP0003718_maternal_effect | 1.82441462 |
| 18 | MP0001501_abnormal_sleep_pattern | 1.80731766 |
| 19 | MP0005671_abnormal_response_to | 1.78792485 |
| 20 | MP0005623_abnormal_meninges_morphology | 1.76595977 |
| 21 | MP0002876_abnormal_thyroid_physiology | 1.71398134 |
| 22 | MP0001542_abnormal_bone_strength | 1.67333986 |
| 23 | MP0000647_abnormal_sebaceous_gland | 1.64382220 |
| 24 | MP0005275_abnormal_skin_tensile | 1.59235696 |
| 25 | MP0009764_decreased_sensitivity_to | 1.59125380 |
| 26 | MP0005174_abnormal_tail_pigmentation | 1.57187942 |
| 27 | MP0009053_abnormal_anal_canal | 1.54368272 |
| 28 | MP0009785_altered_susceptibility_to | 1.49555583 |
| 29 | MP0000015_abnormal_ear_pigmentation | 1.49463818 |
| 30 | MP0003252_abnormal_bile_duct | 1.48431407 |
| 31 | MP0000427_abnormal_hair_cycle | 1.46198361 |
| 32 | MP0005408_hypopigmentation | 1.40665085 |
| 33 | MP0005171_absent_coat_pigmentation | 1.38791840 |
| 34 | MP0004885_abnormal_endolymph | 1.37532324 |
| 35 | MP0000383_abnormal_hair_follicle | 1.36349371 |
| 36 | MP0005645_abnormal_hypothalamus_physiol | 1.35920972 |
| 37 | MP0003172_abnormal_lysosome_physiology | 1.34476946 |
| 38 | MP0004947_skin_inflammation | 1.28663943 |
| 39 | MP0003763_abnormal_thymus_physiology | 1.27224372 |
| 40 | MP0005595_abnormal_vascular_smooth | 1.26066272 |
| 41 | MP0001324_abnormal_eye_pigmentation | 1.23111513 |
| 42 | MP0002796_impaired_skin_barrier | 1.22663670 |
| 43 | MP0001293_anophthalmia | 1.22186992 |
| 44 | MP0008872_abnormal_physiological_respon | 1.21301593 |
| 45 | MP0005387_immune_system_phenotype | 1.18485976 |
| 46 | MP0001790_abnormal_immune_system | 1.18485976 |
| 47 | MP0004084_abnormal_cardiac_muscle | 1.14263534 |
| 48 | MP0003315_abnormal_perineum_morphology | 1.08782250 |
| 49 | MP0005000_abnormal_immune_tolerance | 1.07943393 |
| 50 | MP0005083_abnormal_biliary_tract | 1.06906584 |
| 51 | MP0000534_abnormal_ureter_morphology | 1.06319064 |
| 52 | MP0009745_abnormal_behavioral_response | 1.04820138 |
| 53 | MP0003705_abnormal_hypodermis_morpholog | 1.03277164 |
| 54 | MP0008007_abnormal_cellular_replicative | 1.03033447 |
| 55 | MP0002148_abnormal_hypersensitivity_rea | 1.02918951 |
| 56 | MP0002234_abnormal_pharynx_morphology | 1.02129469 |
| 57 | MP0005257_abnormal_intraocular_pressure | 1.00522088 |
| 58 | MP0009697_abnormal_copulation | 0.97885125 |
| 59 | MP0000026_abnormal_inner_ear | 0.97671872 |
| 60 | MP0002060_abnormal_skin_morphology | 0.97147079 |
| 61 | MP0003448_altered_tumor_morphology | 0.95543307 |
| 62 | MP0005379_endocrine/exocrine_gland_phen | 0.94150194 |
| 63 | MP0001533_abnormal_skeleton_physiology | 0.91904200 |
| 64 | MP0003436_decreased_susceptibility_to | 0.90107205 |
| 65 | MP0005187_abnormal_penis_morphology | 0.87489266 |
| 66 | MP0005023_abnormal_wound_healing | 0.87150582 |
| 67 | MP0005197_abnormal_uvea_morphology | 0.86607117 |
| 68 | MP0002332_abnormal_exercise_endurance | 0.86289725 |
| 69 | MP0001216_abnormal_epidermal_layer | 0.85970557 |
| 70 | MP0003942_abnormal_urinary_system | 0.85246140 |
| 71 | MP0002160_abnormal_reproductive_system | 0.85113047 |
| 72 | MP0009250_abnormal_appendicular_skeleto | 0.85059487 |
| 73 | MP0005503_abnormal_tendon_morphology | 0.84727701 |
| 74 | MP0002102_abnormal_ear_morphology | 0.84645953 |
| 75 | MP0003646_muscle_fatigue | 0.83215845 |
| 76 | MP0002693_abnormal_pancreas_physiology | 0.81260959 |
| 77 | MP0003045_fibrosis | 0.81036671 |
| 78 | MP0005389_reproductive_system_phenotype | 0.80566417 |
| 79 | MP0002295_abnormal_pulmonary_circulatio | 0.80260283 |
| 80 | MP0010678_abnormal_skin_adnexa | 0.79387843 |
| 81 | MP0005501_abnormal_skin_physiology | 0.79089033 |
| 82 | MP0008877_abnormal_DNA_methylation | 0.78808498 |
| 83 | MP0003880_abnormal_central_pattern | 0.76729241 |
| 84 | MP0003879_abnormal_hair_cell | 0.76524213 |
| 85 | MP0001119_abnormal_female_reproductive | 0.76184903 |
| 86 | MP0005508_abnormal_skeleton_morphology | 0.74787504 |
| 87 | MP0009840_abnormal_foam_cell | 0.74371342 |
| 88 | MP0003638_abnormal_response/metabolism_ | 0.74099930 |
| 89 | MP0005025_abnormal_response_to | 0.73180626 |
| 90 | MP0002184_abnormal_innervation | 0.72237475 |
| 91 | MP0005390_skeleton_phenotype | 0.72026807 |
| 92 | MP0002089_abnormal_postnatal_growth/wei | 0.71998080 |
| 93 | MP0002095_abnormal_skin_pigmentation | 0.71646760 |
| 94 | MP0001944_abnormal_pancreas_morphology | 0.71232403 |
| 95 | MP0002736_abnormal_nociception_after | 0.71197605 |
| 96 | MP0002928_abnormal_bile_duct | 0.70924703 |
| 97 | MP0003755_abnormal_palate_morphology | 0.68380248 |
| 98 | MP0000537_abnormal_urethra_morphology | 0.67191057 |
| 99 | MP0003279_aneurysm | 0.66999481 |
| 100 | MP0002006_tumorigenesis | 0.65013671 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Aplasia/hypoplasia of the uterus (HP:0008684) | 4.30469335 |
| 2 | Increased IgM level (HP:0003496) | 4.22804628 |
| 3 | Radial bowing (HP:0002986) | 4.02849607 |
| 4 | Conical tooth (HP:0000698) | 4.01295282 |
| 5 | Aplastic anemia (HP:0001915) | 3.46765679 |
| 6 | Type II lissencephaly (HP:0007260) | 3.46733856 |
| 7 | Eosinophilia (HP:0001880) | 3.46329922 |
| 8 | Aplasia/Hypoplasia of the phalanges of the toes (HP:0010173) | 3.45627519 |
| 9 | IgG deficiency (HP:0004315) | 3.45049355 |
| 10 | Spondylolisthesis (HP:0003302) | 3.43165249 |
| 11 | Autoimmune thrombocytopenia (HP:0001973) | 3.42442614 |
| 12 | Abnormality of dentin (HP:0010299) | 3.36092443 |
| 13 | Hypoplasia of the uterus (HP:0000013) | 3.32888021 |
| 14 | Hypoplastic nipples (HP:0002557) | 3.26947741 |
| 15 | Hypothermia (HP:0002045) | 3.15713284 |
| 16 | Abnormality of the middle phalanges of the toes (HP:0010183) | 3.13907904 |
| 17 | Fibular aplasia (HP:0002990) | 3.07799171 |
| 18 | Increased intramyocellular lipid droplets (HP:0012240) | 2.96325229 |
| 19 | Fair hair (HP:0002286) | 2.93636396 |
| 20 | Adactyly (HP:0009776) | 2.92508116 |
| 21 | Femoral bowing (HP:0002980) | 2.85633200 |
| 22 | Abnormality of incisor morphology (HP:0011063) | 2.85509528 |
| 23 | Hypoplastic labia majora (HP:0000059) | 2.84094608 |
| 24 | Thick nail (HP:0001805) | 2.83701690 |
| 25 | Bowed forearm bones (HP:0003956) | 2.82333664 |
| 26 | Bowing of the arm (HP:0006488) | 2.82333664 |
| 27 | Severe visual impairment (HP:0001141) | 2.81245591 |
| 28 | Abnormality of B cell number (HP:0010975) | 2.71699028 |
| 29 | Focal motor seizures (HP:0011153) | 2.70646015 |
| 30 | Abnormality of the labia majora (HP:0012881) | 2.67230197 |
| 31 | Symphalangism affecting the phalanges of the hand (HP:0009773) | 2.63950064 |
| 32 | Generalized hypopigmentation of hair (HP:0011358) | 2.62627019 |
| 33 | Breast hypoplasia (HP:0003187) | 2.54707905 |
| 34 | Concave nail (HP:0001598) | 2.53653543 |
| 35 | Retinal dysplasia (HP:0007973) | 2.52923615 |
| 36 | Abnormality of macular pigmentation (HP:0008002) | 2.50295912 |
| 37 | Optic neuritis (HP:0100653) | 2.40280191 |
| 38 | Retrobulbar optic neuritis (HP:0100654) | 2.40280191 |
| 39 | Anhidrosis (HP:0000970) | 2.40111605 |
| 40 | Autoimmune hemolytic anemia (HP:0001890) | 2.39560294 |
| 41 | Abnormal pupillary function (HP:0007686) | 2.39282572 |
| 42 | Increased hepatocellular lipid droplets (HP:0006565) | 2.37383322 |
| 43 | B lymphocytopenia (HP:0010976) | 2.36332627 |
| 44 | Increased muscle lipid content (HP:0009058) | 2.30750236 |
| 45 | Exertional dyspnea (HP:0002875) | 2.29720640 |
| 46 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 2.27636531 |
| 47 | Abnormality of alanine metabolism (HP:0010916) | 2.27636531 |
| 48 | Hyperalaninemia (HP:0003348) | 2.27636531 |
| 49 | Granulocytopenia (HP:0001913) | 2.26658743 |
| 50 | Recurrent corneal erosions (HP:0000495) | 2.24358090 |
| 51 | Cheilitis (HP:0100825) | 2.22660106 |
| 52 | Blepharitis (HP:0000498) | 2.20258535 |
| 53 | Ridged nail (HP:0001807) | 2.19394773 |
| 54 | Progressive inability to walk (HP:0002505) | 2.19316404 |
| 55 | Inability to walk (HP:0002540) | 2.19167294 |
| 56 | Cerebellar dysplasia (HP:0007033) | 2.18725802 |
| 57 | Albinism (HP:0001022) | 2.18670184 |
| 58 | Anterior segment dysgenesis (HP:0007700) | 2.18424519 |
| 59 | IgA deficiency (HP:0002720) | 2.18204729 |
| 60 | Petechiae (HP:0000967) | 2.18186778 |
| 61 | Abnormality of the proximal phalanges of the hand (HP:0009834) | 2.16936647 |
| 62 | Corneal dystrophy (HP:0001131) | 2.14660880 |
| 63 | Annular pancreas (HP:0001734) | 2.13583854 |
| 64 | Follicular hyperkeratosis (HP:0007502) | 2.13124080 |
| 65 | Ankle contracture (HP:0006466) | 2.12120066 |
| 66 | 3-Methylglutaconic aciduria (HP:0003535) | 2.11673038 |
| 67 | Hemorrhage of the eye (HP:0011885) | 2.08319322 |
| 68 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.07321342 |
| 69 | Septate vagina (HP:0001153) | 2.06886734 |
| 70 | Abnormality of eosinophils (HP:0001879) | 2.06759741 |
| 71 | Synostosis involving the elbow (HP:0003938) | 2.06075552 |
| 72 | Humeroradial synostosis (HP:0003041) | 2.06075552 |
| 73 | Premature skin wrinkling (HP:0100678) | 2.04537150 |
| 74 | Lipid accumulation in hepatocytes (HP:0006561) | 2.03983533 |
| 75 | Abnormality of the renal cortex (HP:0011035) | 2.03903090 |
| 76 | Mesomelia (HP:0003027) | 2.02738277 |
| 77 | Limb dystonia (HP:0002451) | 2.01969189 |
| 78 | Corneal erosion (HP:0200020) | 2.01672333 |
| 79 | Orchitis (HP:0100796) | 2.00761758 |
| 80 | Congenital stationary night blindness (HP:0007642) | 2.00693518 |
| 81 | Short nail (HP:0001799) | 1.99967415 |
| 82 | Central scotoma (HP:0000603) | 1.99486642 |
| 83 | Tibial bowing (HP:0002982) | 1.98249235 |
| 84 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 1.96927773 |
| 85 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 1.96927773 |
| 86 | Abnormality of the middle phalanx of the 5th finger (HP:0004219) | 1.95834425 |
| 87 | Abnormality of the distal phalanges of the toes (HP:0010182) | 1.94741728 |
| 88 | Fragile nails (HP:0001808) | 1.93773502 |
| 89 | Plantar hyperkeratosis (HP:0007556) | 1.93542189 |
| 90 | Keratoconjunctivitis (HP:0001096) | 1.90597998 |
| 91 | Abnormal finger flexion creases (HP:0006143) | 1.90059798 |
| 92 | Aplasia/Hypoplasia of the middle phalanx of the 5th finger (HP:0009161) | 1.89342679 |
| 93 | Renal Fanconi syndrome (HP:0001994) | 1.88109776 |
| 94 | Oligodactyly (hands) (HP:0001180) | 1.86524256 |
| 95 | Self-mutilation (HP:0000742) | 1.84405618 |
| 96 | Short middle phalanx of the 5th finger (HP:0004220) | 1.84094956 |
| 97 | Hemoptysis (HP:0002105) | 1.82674363 |
| 98 | Abnormal hair laboratory examination (HP:0003328) | 1.81438858 |
| 99 | Keratitis (HP:0000491) | 1.80306799 |
| 100 | Limb hypertonia (HP:0002509) | 1.79000226 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | SIK2 | 4.83947746 |
| 2 | ARAF | 3.82140694 |
| 3 | MAP3K12 | 3.10526929 |
| 4 | BCR | 2.96224492 |
| 5 | ADRBK2 | 2.77921004 |
| 6 | BRD4 | 2.59999166 |
| 7 | TXK | 2.58963351 |
| 8 | MAP3K13 | 2.22375277 |
| 9 | NEK2 | 2.13921306 |
| 10 | BRAF | 2.13822630 |
| 11 | IKBKB | 2.07940251 |
| 12 | NUAK1 | 2.05986031 |
| 13 | MAP3K9 | 1.96468674 |
| 14 | TAOK3 | 1.92241730 |
| 15 | MAP4K2 | 1.90932301 |
| 16 | GRK7 | 1.90769113 |
| 17 | PIM2 | 1.90015371 |
| 18 | MAPK13 | 1.87079611 |
| 19 | PIK3CA | 1.85293958 |
| 20 | NTRK3 | 1.82968435 |
| 21 | TLK1 | 1.76718681 |
| 22 | EPHB2 | 1.76037299 |
| 23 | MYLK | 1.75665064 |
| 24 | DMPK | 1.74350492 |
| 25 | RAF1 | 1.66621044 |
| 26 | MOS | 1.58745399 |
| 27 | NEK6 | 1.54584052 |
| 28 | MAP2K6 | 1.47536998 |
| 29 | EIF2AK1 | 1.37084975 |
| 30 | FRK | 1.36857319 |
| 31 | ACVR1B | 1.35705086 |
| 32 | GRK6 | 1.35000201 |
| 33 | MAP3K14 | 1.30732957 |
| 34 | KSR1 | 1.30290406 |
| 35 | GRK1 | 1.29709508 |
| 36 | JAK3 | 1.22919006 |
| 37 | BUB1 | 1.22648629 |
| 38 | TGFBR1 | 1.20799026 |
| 39 | NEK9 | 1.16709960 |
| 40 | PRKCI | 1.12066837 |
| 41 | TEC | 1.04532783 |
| 42 | ADRBK1 | 1.02812617 |
| 43 | TBK1 | 1.00137552 |
| 44 | MAPK11 | 0.95729932 |
| 45 | DDR2 | 0.88654707 |
| 46 | WNK3 | 0.81081366 |
| 47 | CHUK | 0.78896862 |
| 48 | TGFBR2 | 0.78800294 |
| 49 | NLK | 0.78438591 |
| 50 | IKBKE | 0.77765133 |
| 51 | FLT3 | 0.71541298 |
| 52 | GRK5 | 0.70605856 |
| 53 | PRKCG | 0.70437814 |
| 54 | MAPKAPK3 | 0.68562507 |
| 55 | MARK1 | 0.67228048 |
| 56 | CDK19 | 0.66698015 |
| 57 | PRKCD | 0.65539240 |
| 58 | FGFR2 | 0.64847284 |
| 59 | MAP3K7 | 0.64160728 |
| 60 | NTRK1 | 0.62119092 |
| 61 | LATS2 | 0.59008156 |
| 62 | CHEK2 | 0.58642407 |
| 63 | MAPK10 | 0.55778025 |
| 64 | MST1R | 0.55126298 |
| 65 | MAP2K1 | 0.53882031 |
| 66 | EEF2K | 0.52526574 |
| 67 | INSR | 0.52447413 |
| 68 | PRKCH | 0.52147196 |
| 69 | PRKCE | 0.52124080 |
| 70 | CDK8 | 0.51836490 |
| 71 | PNCK | 0.51435543 |
| 72 | OXSR1 | 0.50253698 |
| 73 | CDK3 | 0.50249513 |
| 74 | ROCK1 | 0.48495695 |
| 75 | CDK12 | 0.46834066 |
| 76 | EIF2AK2 | 0.46157922 |
| 77 | PKN1 | 0.46020471 |
| 78 | PAK1 | 0.43789421 |
| 79 | MAPKAPK5 | 0.41488759 |
| 80 | LMTK2 | 0.40690583 |
| 81 | ILK | 0.40584269 |
| 82 | CDK4 | 0.40381889 |
| 83 | CSK | 0.39778914 |
| 84 | CSNK1D | 0.39594837 |
| 85 | PAK2 | 0.38264503 |
| 86 | PRKCA | 0.34045327 |
| 87 | CSF1R | 0.33255397 |
| 88 | KSR2 | 0.31795471 |
| 89 | MAPK9 | 0.30910051 |
| 90 | PDK1 | 0.28862025 |
| 91 | TRPM7 | 0.28393496 |
| 92 | CAMK2A | 0.27979337 |
| 93 | PRKACA | 0.27558967 |
| 94 | PRKG1 | 0.27310081 |
| 95 | PLK1 | 0.26921825 |
| 96 | MAP3K10 | 0.25762581 |
| 97 | ZAK | 0.25713295 |
| 98 | RPS6KB1 | 0.25498661 |
| 99 | PHKG2 | 0.24902664 |
| 100 | PHKG1 | 0.24902664 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 3.63271256 |
| 2 | Primary immunodeficiency_Homo sapiens_hsa05340 | 3.11029501 |
| 3 | Nicotine addiction_Homo sapiens_hsa05033 | 3.00428858 |
| 4 | Caffeine metabolism_Homo sapiens_hsa00232 | 2.61263736 |
| 5 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.60299964 |
| 6 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 2.51113951 |
| 7 | Basal transcription factors_Homo sapiens_hsa03022 | 2.37648905 |
| 8 | Phototransduction_Homo sapiens_hsa04744 | 2.18865531 |
| 9 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 2.13346178 |
| 10 | Antigen processing and presentation_Homo sapiens_hsa04612 | 2.07762198 |
| 11 | ECM-receptor interaction_Homo sapiens_hsa04512 | 2.03062486 |
| 12 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.88876468 |
| 13 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 1.85810061 |
| 14 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.81093270 |
| 15 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.63576779 |
| 16 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.57904391 |
| 17 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.53945088 |
| 18 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.50079331 |
| 19 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.40378776 |
| 20 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 1.34517781 |
| 21 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.32639431 |
| 22 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.30370688 |
| 23 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.29997538 |
| 24 | Allograft rejection_Homo sapiens_hsa05330 | 1.23759663 |
| 25 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.19937449 |
| 26 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.15490406 |
| 27 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 1.14993090 |
| 28 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 1.12811063 |
| 29 | Salivary secretion_Homo sapiens_hsa04970 | 1.11686472 |
| 30 | Morphine addiction_Homo sapiens_hsa05032 | 1.08770219 |
| 31 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.07861906 |
| 32 | Olfactory transduction_Homo sapiens_hsa04740 | 1.05755166 |
| 33 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 1.05080433 |
| 34 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.00787828 |
| 35 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.00280513 |
| 36 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.97675515 |
| 37 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.94691527 |
| 38 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.94544198 |
| 39 | RNA degradation_Homo sapiens_hsa03018 | 0.92402089 |
| 40 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.91055774 |
| 41 | GABAergic synapse_Homo sapiens_hsa04727 | 0.89942263 |
| 42 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.88587232 |
| 43 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.88223009 |
| 44 | Taste transduction_Homo sapiens_hsa04742 | 0.88156630 |
| 45 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.86227410 |
| 46 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.84713198 |
| 47 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.83761380 |
| 48 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.83042393 |
| 49 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.82883601 |
| 50 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.79617478 |
| 51 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.78761771 |
| 52 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.78712898 |
| 53 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.78316347 |
| 54 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.78012868 |
| 55 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.77733626 |
| 56 | Apoptosis_Homo sapiens_hsa04210 | 0.76818675 |
| 57 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.76570651 |
| 58 | Long-term depression_Homo sapiens_hsa04730 | 0.75117253 |
| 59 | Focal adhesion_Homo sapiens_hsa04510 | 0.73510023 |
| 60 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.67787971 |
| 61 | Histidine metabolism_Homo sapiens_hsa00340 | 0.66861983 |
| 62 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.66073296 |
| 63 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.65952634 |
| 64 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.64705228 |
| 65 | Proteasome_Homo sapiens_hsa03050 | 0.64666239 |
| 66 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.62110522 |
| 67 | Hepatitis B_Homo sapiens_hsa05161 | 0.61559676 |
| 68 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.60664391 |
| 69 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.60461726 |
| 70 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.60029164 |
| 71 | Cocaine addiction_Homo sapiens_hsa05030 | 0.58596273 |
| 72 | Malaria_Homo sapiens_hsa05144 | 0.58259149 |
| 73 | Melanoma_Homo sapiens_hsa05218 | 0.57511913 |
| 74 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.54799085 |
| 75 | Alzheimers disease_Homo sapiens_hsa05010 | 0.54058589 |
| 76 | Asthma_Homo sapiens_hsa05310 | 0.52380636 |
| 77 | Circadian entrainment_Homo sapiens_hsa04713 | 0.52309469 |
| 78 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.52047349 |
| 79 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.51140776 |
| 80 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.48747359 |
| 81 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.46658040 |
| 82 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.46593047 |
| 83 | Prion diseases_Homo sapiens_hsa05020 | 0.45825947 |
| 84 | Purine metabolism_Homo sapiens_hsa00230 | 0.45249347 |
| 85 | Protein export_Homo sapiens_hsa03060 | 0.43434744 |
| 86 | Parkinsons disease_Homo sapiens_hsa05012 | 0.42897116 |
| 87 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.42576548 |
| 88 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.42190665 |
| 89 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.41990882 |
| 90 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.40566269 |
| 91 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.40283834 |
| 92 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.40027946 |
| 93 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.39965952 |
| 94 | Measles_Homo sapiens_hsa05162 | 0.39885674 |
| 95 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.38598045 |
| 96 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.38577094 |
| 97 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.38383745 |
| 98 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.36761649 |
| 99 | RNA polymerase_Homo sapiens_hsa03020 | 0.36158983 |
| 100 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.35453926 |

